Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Early Treatment of COVID-19
NCT04438850Phase 2Terminated
- Sponsor
- IRCCS Ospedale Sacro Cuore Don Calabria
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by IRCCS Ospedale Sacro Cuore Don Calabria. Started Jul 2020; status: terminated.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04438850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04438850.